Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists [MoA] - N0000191546
Pharmacologic Class Information
| Pharmacologic Code | N0000191546 |
| Pharmacologic Name | Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists |
| Pharmacologic Uses |
|
| Pharmacologic Concept | Mechanisms of Action - [MoA] |
| Pharmacologic Concept Description | This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept. |
NDC Products with Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists
The table contains 3 products whose active ingredient are classified under the same pharmacologic class Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists [MoA].
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
|---|---|---|---|---|---|---|---|
| 55513-800 | Corlanor | Non-Proprietary Name: Ivabradine | Tablet, Film Coated | Oral | Amgen Inc | ACTIVE | |
| 55513-810 | Corlanor | Non-Proprietary Name: Ivabradine | Tablet, Film Coated | Oral | Amgen Inc | ACTIVE | |
| 55513-813 | Corlanor | Non-Proprietary Name: Ivabradine | Solution | Oral | Amgen Inc | ACTIVE |